Rising Danger of E-cigarettes in Brazil: Evali and Health Implications

Regulations by 2FIRSTS.ai
Dec.27.2023
Rising Danger of E-cigarettes in Brazil: Evali and Health Implications
The high number of smokers in Campo Grande, Brazil, has raised concerns as experts warn of a new lung disease caused by e-cigarettes.

According to recent reports from Brazilian news outlet Correiodoestado, data collected through telephone surveys (Vigitel 0) for monitoring risk and protective factors reveals a high number of smokers in the city. Among them, 6.9% are male and 8.6% are female.

 

As more and more individuals adopt the use of e-cigarettes, medical experts are issuing warnings about a newly emerging lung illness called Evali, specifically caused by the use of e-cigarettes.

 

Healthcare professionals are engaged in a battle against e-cigarettes, according to respiratory disease expert Henrique Ferreira de Brito, as these devices are deemed more harmful than conventional cigarettes.

 

Although e-cigarette devices, also known as Electronic Smoking Devices (DEF), do not burn tobacco, their nicotine content is higher than that of "regular" cigarettes, resulting in greater and faster dependency.

 

Doctors say that e-cigarettes have a higher dependency, contain higher levels of nicotine, and can reach the human brain faster, resulting in a dependency on nicotine additives. Therefore, in addition to the inherent dangers of nicotine itself, e-cigarettes also contain other substances different from traditional cigarettes that pose serious health risks.

 

The doctor further explained that these substances are associated with various diseases, including heart disease, lung disease, cardiovascular disease, cancer, and Evali.

 

The São Paulo Research Foundation (Fapesp) has published an article revealing a brief history of this new type of lung disease, which was first discovered in the United States in 2009.

 

At the time, many young people in their twenties, some of whom had never suffered from respiratory diseases before, were experiencing symptoms such as difficulty breathing, coughing, and chest pains in American hospitals. Additionally, many individuals also reported abdominal pain, nausea, vomiting, diarrhea, fatigue, fever, and weight loss.

 

According to this historical record, all patients have one common factor: they are all users of e-cigarettes. In Brazil, there have been recorded cases of Evali, some of which also exhibit typical symptoms of viral pneumonia caused by Covid-19.

 

A recent study conducted by the Brazilian Institute of Geography and Statistics (IBGE) revealed that the teenage e-cigarette usage rate in Campo Grande is the highest in Brazil, with 0.9% of ninth-grade students having already tried e-cigarettes.

 

Doctors have warned that the sale, import, distribution, and marketing of e-cigarettes are prohibited under Resolution of the Collegiate Board. Although the use itself is not banned, currently all buying and selling is prohibited. Young people are particularly susceptible to the allure of e-cigarettes and may mistakenly believe they are harmless. However, this is a lie, as e-cigarettes, even those without nicotine, pose significant health risks.

 

Doctors say that factors contributing to the difficulties of quitting smoking include the release of dopamine when nicotine is consumed. Users constantly crave that feeling, which leads to an escalation in both frequency and quantity of smoking. However, in addition to chemical dependence, there are also psychological and physiological dependencies.

 

In order to quit smoking, doctors recommend that besides the individual's determination, they should also have a medical team consisting of a nutritionist, a psychologist, and a pulmonary specialist to accompany them. These professionals will assist in changing habits and utilize medications that aid in improving the chemical dependency sensation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

STG UK refreshes XQS nicotine pouch packaging: new flavour indicators, hitting retail from March
STG UK refreshes XQS nicotine pouch packaging: new flavour indicators, hitting retail from March
Scandinavian Tobacco Group UK (STG UK) has announced a rebrand across its XQS nicotine pouch range. The updated packaging will be visible at retail from March, with the recommended retail price remaining £5.50. The new packs feature a bolder logo and glossy textures, retain nicotine strength indicators, and add a side flavour profile indicator to show the flavour type.
Feb.28 by 2FIRSTS.ai
Philippine Tobacco Control Coalition Backs Raising Legal Age for Vape and Tobacco Products to 25
Philippine Tobacco Control Coalition Backs Raising Legal Age for Vape and Tobacco Products to 25
A coalition of health and child rights advocates in the Philippines said it supports Health Secretary Teodoro Herbosa’s call to raise the legal age restriction for vape and tobacco products from 18 to 25. The group said scientific evidence shows that the brain of a young person continues to develop until the mid-20s, and that nicotine exposure during that period can cause lasting impairment in impulse control, learning, and mood regulation.
Mar.11 by 2FIRSTS.ai
Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem Drops Texas Lawsuit and Plans to Refile in D.C. Over FDA Handling of Zone Application
Fontem US, the maker and seller of Zone nicotine pouches, has voluntarily dismissed its lawsuit against the U.S. Food and Drug Administration, which it had accused of unfairly delaying its market application.
Mar.25 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11
Special Report | Tax Veteran Takes Helm at China’s Tobacco Regulator, Leadership Change Fuels Reform Watch
Special Report | Tax Veteran Takes Helm at China’s Tobacco Regulator, Leadership Change Fuels Reform Watch
China’s tobacco system has appointed a new top internal leader with a long background in public finance and taxation, drawing renewed attention to whether the country’s tobacco monopoly may enter a new phase of reform debate. The appointment itself does not signal a defined policy shift.But it places a veteran fiscal official at the center of a key state sector amid unresolved questions on tax reform, structure, and emerging tobacco products.
Mar.20
Haypp Reports 15% Q4 Sales Growth as Nicotine Pouch Volumes Rise
Haypp Reports 15% Q4 Sales Growth as Nicotine Pouch Volumes Rise
Haypp Group announced that net sales for October–December 2025 rose 15% year-on-year to SEK 1,052.2 million, or 19% in constant currency terms. The company recorded 28% volume growth in the nicotine pouch category during the quarter. The number of orders increased to 1.34 million, and active consumers rose to 630,000, marking the highest level in the company’s history. CEO Gavin O’Dowd said the company’s accelerating topline performance in the US and UK positions it for a strong 2026.
Market
Feb.22